Status | Study |
Recruiting |
Study Name: A 6 Month, Open-Label, Pilot Futility Clinical Trial of Oral Salsalate for Progressive Supranuclear Palsy Condition: Progressive Supranuclear Palsy Date: 2015-04-09 Interventions: Drug: Salsalate Salsalate is a non-acetylated dimer of salicylic acid, and is classified as a NSAID. The |
Completed |
Study Name: Rehabilitation in Patients With Progressive Supranuclear Palsy Condition: Progressive Supranuclear Palsy Date: 2014-03-25 Interventions: Other: MIRT |
Completed |
Study Name: Clinical Trial to Evaluate Bone Marrow Stem Cell Therapy for PSP, a Rare Form of Parkinsonism Condition: Progressive Supranuclear Palsy Date: 2013-03-31 Interventions: Biological: stem cell therapy Bone marrow will be collected from the iliac crest under local anesthesia. |
Completed |
Study Name: Postural Instability in Progressive Supranuclear Palsy Condition: Progressive Supranuclear Palsy Parkinson's Disease Date: 2012-03-22 |
Completed |
Study Name: Alpha-lipoic Acid/L-acetyl Carnitine for Progressive Supranuclear Palsy Condition: Progressive Supranuclear Palsy Date: 2012-01-09 Interventions: Drug: alpha-lipoic acid and L-acetyl carnitine alpha-lipoic acid and L-acetyl carnitine capsules, 600mg/ |
Terminated |
Study Name: Efficacy, Tolerability and Safety of Azilect in Subjects With Progressive Supranuclear Palsy Condition: Progressive Supranuclear Palsy Date: 2010-08-20 Interventions: Drug: Rasagiline tablet once d |
Completed |
Study Name: Study to Evaluate the Safety and Efficacy of Davunetide for the Treatment of Progressive Supranuclear Palsy Condition: Progressive Supranuclear Palsy Date: 2010-04-23 Interventions: Drug: Davunetide Davunetide Na |
Completed |
Study Name: Safety, Tolerability, and Efficacy of Two Different Oral Doses of NP031112 Versus Placebo in the Treatment of Patients With Mild-to-Moderate Progressive Supranuclear Palsy Condition: Progressive Supranuclear Palsy Date: 2010-01-13 Interventions: Drug: tideglusib 800 mg of tid |
Completed |
Study Name: A Pilot Trial of Lithium in Subjects With Progressive Supranuclear Palsy or Corticobasal Degeneration Condition: Progressive Supranuclear Palsy Corticobasal Degeneration Date: 2008-06-20 Interventions: Drug: Lithium All participants will receive lithium. The dosage will be titrated over a 5-week period an |
Completed |
Study Name: A Pilot Clinical Trial of Pyruvate, Creatine, and Niacinamide in Progressive Supranuclear Palsy. Condition: Progressive Supranuclear Palsy Date: 2008-01-14 Interventions: Dietary Supplement: Pyruvate, creatine, niacinamide |